APA (7th ed.) Citation

Pan, Y., Lin, C., Lu, C., Li, L., Wang, Y., Chen, H., & He, Y. (2018). Metformin synergistically enhances the antitumor activity of the third‐generation EGFR‐TKI CO‐1686 in lung cancer cells through suppressing NF‐κB signaling. Clinical Respiratory Journal, 12(12), 2642. https://doi.org/10.1111/crj.12970

Chicago Style (17th ed.) Citation

Pan, Yong‐Hong, Cai‐Yu Lin, Cong‐Hua Lu, Li Li, Yu‐Bo Wang, Heng‐Yi Chen, and Yong He. "Metformin Synergistically Enhances the Antitumor Activity of the Third‐generation EGFR‐TKI CO‐1686 in Lung Cancer Cells Through Suppressing NF‐κB Signaling." Clinical Respiratory Journal 12, no. 12 (2018): 2642. https://doi.org/10.1111/crj.12970.

MLA (9th ed.) Citation

Pan, Yong‐Hong, et al. "Metformin Synergistically Enhances the Antitumor Activity of the Third‐generation EGFR‐TKI CO‐1686 in Lung Cancer Cells Through Suppressing NF‐κB Signaling." Clinical Respiratory Journal, vol. 12, no. 12, 2018, p. 2642, https://doi.org/10.1111/crj.12970.